The ‘golden age’ for research tools: Parse Biosciences raises $41.5M for single-cell tech
GeekWire
FEBRUARY 15, 2022
Parse Biosciences CTO Charles Roco and CEO Alex Rosenberg. The Seattle-based company is an entry in the nascent field of single-cell RNA sequencing, where multiple methods have been developed and companies are jostling for long-term dominance. The company sells three kits with accompanying software. Parse Photo). Parse Image).
94 
Let's personalize your content